RATIONALE: Obesity increases asthma severity. Weight loss in bariatric surgery improves asthma symptoms and reduces airway hyperresponsiveness. We hypothesized that vertical sleeve gastrectomy (VSG), a model of bariatric surgery, would reduce airway pathology in allergen-challenged obese mice. METHODS: Five-week old C57BL6 mice were fed a high fat diet (HFD -45% kcal fat) or normal chow and concurrently challenged with intranasal house dust mite (HDM) allergen (25 mg) or saline 3 days/week for 8 weeks. These challenged mice immediately underwent VSG or sham surgery, or no surgery (NS) as control (n55 per group). After one-week recovery, mice were returned to HFD and HDM challenges for four weeks. Twenty-four hours after the final HDM challenge, the mice were tested for airway responsiveness to increasing doses of methacholine delivered intravenously, and lung mechanics were evaluated using Flexivent (SciReq). Blood and bronchoalveolar lavage (BAL) with saline were collected. Harvested lung slices were stained with Masson's trichrome, Periodic acid Schiff or hematoxylin and eosin stains. Percent trichrome staining was quantified using Image J (NIH). Interleukin (IL)-13, IL-5, glucagon-like peptide-1, transforming growth factor-beta, insulin and leptin were measured in blood and/or lavage fluid using ELISA. RESULTS: VSG induced significant weight loss and reduction of plasma leptin levels (p<0.05). Airway reactivity to bronchoconstrictor, airway tissue inflammation and percent BAL eosinophils (13.3% NS, 4.7% sham, 0.8% VSG) were reduced in HFD-fed, HDM-challenged mice following VSG compared to sham or NS (p<0.05). CONCLUSIONS: Weight loss surgery in obese, chronically allergenchallenged mice induces metabolic changes associated with improved airway inflammation and resistance.
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Therapeutic effects of pravastatin on asthmatic airway inflammation in high fat diet induced obese mouse asthma model. Hwayoung Lee, MD, PhD, Jung Hur, PhD, Chin Kook Rhee, MD, PhD, Ji Young Kang, MD, PhD, and Sook Young Lee, MD, PhD; Seoul St Mary's hospital, Seoul, Korea, Republic of (South). RATIONALE: Obesity is one of factors associated with severe, uncontrolled asthma. Th17 signaling pathway is known to be associated with obese asthmatics, however effect of pravastatin on obese asthmatic airway inflammation has not been evaluated. METHODS: C57BL/6 mice was fed with high-fat diet (HFD) to induce obesity with or without ovalbumin (OVA) sensitization and challenge. Pravastatin was administered intraperitoneally during the OVA treatment. Airway inflammation, airway hyper-responsiveness (AHR) were analyzed and lung tissues were examined to evaluate the change of bronchial inflammation by pravastatin in obese asthma mice. The changes of MAPK, STAT3 and PI3K/Akt signaling pathways which were known to be stimulated by leptin were measured in lung tissues. RESULTS: HFD exacerbated eosinophilic airway inflammation and increased AHR. Pravastatin successfully alleviated the airway inflammation and AHR in HFD+OVA mice as well as OVA challenged mice. The levels of cytokines examined in bronchoalveolar lavage fluid (BAL) revealed that expression of IL-4, 5 and IL17 were more elevated in HFD+OVA mice than OVA mice reflecting both Th2 and Th17 pathways were stimulated by HFD induced obesity and OVA challenge. Leptin/ adiponectin ratio was elevated in HFD+OVA mice, decreased with pravastatin administration. Treatment of pravastatin suppressed expression of IL-4, 5 and IL-17 in obese OVA mice. Moreover, phosphorylation of p38 (Lin, Sca1, CD11c, CD34, ST2) and cytokines (IL-4, IL-5, IL-10). We also quantified eosinophil chemotaxis in different glycemic conditions. RESULTS: Terminal IL-5-driven eosinophil proliferation, differentiation, and maturation were suppressed in hyperglycemic conditions. IL-4 expression was significantly induced in eosinophils in both acute and chronic hyperglycemia, but acutely suppressed in insulin-and indinavirtreated cells. Siglec-F expression was significantly reduced in mature indinavir-treated eosinophils compared to controls (from an average of 76% to 50%). Moreover, hyperglycemia significantly suppressed eosinophil chemotaxis to eotaxin (CCL11). CONCLUSIONS: Differentiation, chemotaxis, and IL-4 expression in eosinophils are all sensitive to glucose levels in the environment. Disrupted glucose metabolism may be a linking factor for eosinophil responses in obesity, asthma, and inflammation.
